Massachusetts General Hospital, Massachusetts Eye & Ear, Advancing Novel Experimental Gene-Based COVID-19 Vaccine, AAVCOVID
May 06, 2020
May 06, 2020
BOSTON, Massachusetts, May 6 -- Massachusetts General Hospital issued the following news release:
Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham, announced progress towards the testing and development of an experimental vaccine called AAVCOVID, a novel gene-based vaccine candidate against SARS-CoV2, the virus that causes COVID-19.
The AAVCOVID vaccine program was developed in the laboratory of Luk H. Vandenberghe, PhD . . .
Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham, announced progress towards the testing and development of an experimental vaccine called AAVCOVID, a novel gene-based vaccine candidate against SARS-CoV2, the virus that causes COVID-19.
The AAVCOVID vaccine program was developed in the laboratory of Luk H. Vandenberghe, PhD . . .